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Abstract
Carcinoma in situ (CIS) represents the preinvasive
stage of human germ cell tumors, but the mechanism
leading to pubertal proliferation and invasive malig-
nancy remains unknown. Among testicular gap junc-
tional proteins, connexin 43 (Cx43) represents the
predominant Cx, and, previously, an inverse correlation
between synthesis of Cx43 protein and progression of
tumor development was detected. In the present study,
using cDNA microarray analysis, in situ hybridization,
semiquantitative reverse transcription–polymerase
chain reaction (RT-PCR) from tissue homogenates,
RT-PCR from microdissected tubules with normal
spermatogenesis and CIS, and seminoma cells from
invasive seminoma, we asked whether reduction of
Cx43 protein is accompanied by a change of Cx43 tran-
scripts. We detected a significant downregulation of
Cx43 at mRNA level in Sertoli and germ cells starting in
seminiferous tubules infiltrated with CIS and resulting
in a complete loss in seminoma cells. It was demon-
strated that downregulation of Cx43 expression in neo-
plastic human testis takes place at the transcriptional
level andstarts inCIS. This reductionofCx43expression
further suggests that early intratubular derangement in
Cx43 gene expression and disruption of intercellular
communication between Sertoli cells and/or Sertoli and
preinvasive tumor cells may play a role in the progres-
sion phase of human seminoma development.
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Introduction
Testicular germ cell tumor is the most common cancer
among men aged 17 to 45 years [1]. It comprises a variety
of histologic features with two major subtypes, seminoma
and nonseminoma [2]. It is known that there are two periods
of major changes in gene expression: first at the transition
from primordial germ cells to pre-spermatogonia, and later
during the pubertal switch from mitotic to meiotic cell division
[3]. The transformation of the common precursor, the carci-
noma in situ (CIS) cell, to atypical germ cells has been sug-
gested to take place in gonocytes at 7 to 10 weeks of gestation
[4–6]. It has further been suggested that testicular cancer
progressionmay be correlated with an impaired status of Sertoli
cell differentiation [7–11]. In recent years, several genes and
chromosomal aberrations have been identified that are con-
sidered to be involved in the pathogenesis of testicular germ
cell tumorigenesis [12–14], but the molecular mechanism
leading to an increased proliferation of CIS cells at puberty
followed by progression to invasive malignancy after long la-
tency remains still unknown.
Gap junctions contain channels that connect neighboring
cells and constitute the basis for direct intercellular commu-
nication [15]. These channels are composed of connexin (Cx)
protein subunits. Different subtypes of Cx are expressed in an
overlapping spatiotemporal and cell-type-specific pattern [16].
Thus, Cx can be used as specific cellular differentiationmarkers
[17]. In addition, gap junctions play an important role in the
maintenance of normal cell growth so that genes for the Cx
proteins form a family of tumor suppressor genes [18]. The
occurrence of gap junctions in the seminiferous epithelium of
different species has been firmly established [19]. Among
testicular Cx, Cx43 is the predominant Cx and can be ex-
pressed by Sertoli cells, spermatogonia, spermatocytes, peri-
tubular cells, and Leydig cells [19–22]. Testicular gap junctions
containing Cx43 seem to be necessary for the regulation of
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differentiation of Sertoli cells, the controlled interaction and
communication of Sertoli and germ cells, and the coordi-
nated start of differentiation and proliferation of normal germ
cells at puberty [19–22]. Cx43 is also present in the endo-
thelial cells of large- and small-caliber blood vessels, where
the protein coexists with Cx40 and Cx37 [23,24]. Cx37 is
known to be expressed in the vascular endothelium includ-
ing testicular blood vessels and seems to play a role in vas-
cular development [16,25,26].
Cx43 as a phosphoprotein demonstrates multiple elec-
trophoretic isoforms when analyzed by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), in-
cluding a faster migrating form that includes nonphosphory-
lated (P0 or NP) Cx43 and at least two slower migrating
forms, commonly termed P1 and P2. Both P1 and P2 co-
migrate with P0 following alkaline phosphatase treatment,
suggesting that phosphorylation is the primary covalent
modification detected in SDS-PAGE analysis [27,28]. This
phosphorylation of Cx43 in its life cycle has been implicated
in the regulation of a broad variety of Cx processes, such as
the trafficking, assembly/disassembly, degradation, as well
as the gating of gap junction channels [29,30]. In addition,
Cx43 phosphorylation is known to play a role in gap junc-
tional plaque formation and activity [27].
So far, some studies have been published investigating
the presence of gap junctions and Cx43 in seminiferous tu-
bules and pathologic human testes. Seminiferous tubules
showing spermatogenic arrest at the level of spermatogonia,
those with Sertoli-cell-only (SCO) syndrome and infiltrated
with CIS cells display an intratubular reduction or loss of
Cx43 protein [10,21,22,31]. In a recent study, an aberrant
cytoplasmic localization of Cx43 protein was detected in
tumor cells of four patients with seminoma and in neoplastic
cells originating from the JKT-1 seminoma cell line [32].
Thus, alterations of Cx43 protein synthesis can be correlated
to various testicular disorders and male infertility including
cancer [10,21,31–35].
To date, there are no reports associating abnormalities in
intratubular Cx43 gene expression with spermatogenic im-
pairment in the context of the development of testicular
human seminoma from CIS. The present work at mRNA
level extends an earlier study on the expression of the tumor
suppressor Cx43 in CIS of adult patients [10] that revealed
an inverse correlation of Cx43 protein synthesis between
Sertoli cells and abnormal preinvasive germ cells. As alter-
ations of Cx protein synthesis in neoplasms are not always
paralleled by changes in mRNA expression and because
some tumors can express steady-state transcripts without
observable immunoreactivity, indicating that they are able
to downregulate Cx immunoreactivity independently of
mRNA abundance [36,37], we aimed to elucidate whether
a reduction of Cx43 protein is accompanied by a down-
regulation of Cx43 transcripts using cDNA microarray analy-
sis, in situ hybridization (ISH), semiquantitative reverse
transcription-polymerase chain reaction (RT-PCR) from tis-
sue homogenates, and RT-PCR from microdissected tu-
bules with normal spermatogenesis and CIS, and from
seminoma cells from invasive seminoma.
Material and Methods
Testicular Tissue
After obtaining written informed consent, investigations
were performed on biopsies from 10 patients (age 28–
52 years; mean 32.4 years) with obstructive azoospermia
and histologic normal spermatogenesis, 4 patients (age 58–
67; mean 62 years) orchiectomized for prostate carcinoma
revealing histologic normal spermatogenesis, 20 patients
(age 20–45 years; mean 33.8 years) with CIS of the testis
and impaired spermatogenesis, and 40 patients (age 25–
57 years; mean 39 years) with different stages of seminoma
(22 pT1, 14 pT2 and 4 pT3). Patients were not treated
with any drugs before surgery.
Fixation, Embedding, and Histologic Evaluation
Testicular biopsy specimens were cut into two equal
pieces. One part was fixed by immersion in Bouin’s fixative
and embedded in paraffin wax using standard techniques.
Sections (5mm) were stained with hematoxylin and eosin
and scored, according to Bergmann and Kliesch [38]. The
other part was snap-frozen in liquid nitrogen. Diagnosis of
CIS and/or seminoma was established by histologic and
morphologic examination of the biopsy specimen and by
placental alkaline phosphatase (PlAP) immunostaining.
cDNA Microarray Analyses
We compared the gene expression profiles of cells of the
40 seminoma from different patients described above in
different stages (pT1, pT2, pT3) with three normal testes
using tissue homogenates and cDNA microarrays focusing
on the predominant testicular Cx, Cx43 (probe set ID
32531_at, accession no. NM_000165; corresponding Cx
primer sequences can be viewed using probe set IDs under
http://www.affymetrix.com/analysis/netaffx/). Additionally,
the expression pattern of other Cx was investigated: Cx31
(probe set ID 41076_at, accession no. AF099730), Cx31.1
(38903_at, accession no. AF099731), Cx32 (39598_at, ac-
cession no. X04325), Cx37 (40687_at, accession no.
M96789), Cx47 (39504_at, accession no. AF014643, and
39505_at, accession no. AW007036), and Cx50 (31778_at,
accession no. U34802). Testicular tissues used for micro-
array analyses were lysed in TRIzol (Life Technologies,
Karlsruhe, Germany) and total cellular RNA was prepared
using theRNeasyMini Kit (Qiagen,Hilden, Germany) accord-
ing to the manufacturer’s protocol. RNA quality was con-
trolled spectrophotometrically and by gel electrophoresis.
Microarray analyses were carried out applying HG-U95Av2
microarrays (Affymetrix, Santa Clara, CA) from 5 mg of total
RNA. Fragmentation of cRNA, hybridization, washing, stain-
ing, and scanning was performed following the manufac-
turer’s protocols. Expression values were obtained using
Affymetrix Microarray Suite Version 5.0. This includes the
background correction of the average of the lowest two
percentiles of intensities on a 4 4 grid on the chip, the intro-
duction of an ‘‘ideal mismatch’’ forced to be lower than
the corresponding perfect match, and the use of Tukey’s bi-
weight to elicit an expression value out of single probe
500 Connexin 43 Expression in Seminoma Development Brehm et al.
Neoplasia . Vol. 8, No. 6, 2006
intensity pairs. Annotation of the probe sets was taken from
the annotation files provided on the Affymetrix home page
(version updated inOctober 2003). Exploratory data analysis,
Wilcoxon paired nonparametric tests for difference, and
the Mann-Whitney test for the nonparametric independent
two-group comparisons were performed with the program
SPSS 10 for Windows (SPSS Inc, Chicago, IL) and Microsoft
Excel 2000 (Microsoft Corp, Redmond, WA). Differences
with P < .05 were regarded as statistically significant.
To confirm the Cx43 (accession no. NM_000165) expres-
sion data, we performed RT-PCR with tissue homogenate
from 20 patients (5 normal testes and 15 seminoma tissues)
using the following primer pairs: 5V-AGG AGT TCA ATC ACT
TGG CGT GAC-3V as forward primer and 5V-GGC TCA GCG
CACCAC TGG TCGCA-3V as reverse primer. Becausemost
of the frequently used housekeeping genes were differen-
tially expressed in seminoma [39,40], the ubiquitin B (UBB)
housekeeping gene, which was found to be constantly
expressed in seminoma, was chosen for this approach and
coamplified as internal standard control. For semiquantita-
tive examination, UBB primer pairs (5V-GGC TTT GTT GGG
TGA GCT TG-3V as forward primer and 5V-CTG GGC TCC
ACC TCC AGA GT-3V as reverse primer) were added in the
same tube to the Cx43 primers. PCR conditions were as fol-
lows: 1  94jC for 2 minutes, 30  (94jC for 1 minute, 63jC
for 1 minute, 72jC for 1 minute), 72jC for 4 minutes. The
generated PCR products were size-fractionated on a 2%
agarose gel and detected by ethidium bromide staining. The
degree of Cx43 expression was evaluated densitometrically
applying the Scion Image software (Scion Corporation,
Frederick, MD) and correlated to the expression of UBB.
Experiments were repeated at least three times.
UV Laser–Assisted Microdissection, Laser Pressure
Catapulting, RNA Extraction, and RT-PCR
Microdissection followed by RT-PCR was performed on
biopsies from four patients with histologically normal sper-
matogenesis, on four patients showing CIS, and on three
biopsies from patients with seminoma (1 pT1, 1  pT2, 1 
pT3) using the PALM MicroBeam system (PALM, Bernried,
Germany). The system consisted of a nitrogen laser of high
beam precision (wavelength 337 nm), which was coupled to
an inverted microscope (Axiovert 135; Zeiss, Jena, Germany)
using the epifluorescence illumination path. The microscope
stage was digitally controlled and moved by a computer
mouse. The PALM Membrane Slides were irradiated with
an ultraviolet lamp for 30 minutes to achieve better adhesion
of the sections. For histologic evaluation, the sections were
stained with hematoxylin and dehydrated. Tubules of in-
terest were identified by light microscopy and PlAP immuno-
staining (CIS tubules) and separated from the adjacent
interstitial tissue by laser microdissection. With a laser shoot
the chosen seminiferous tubules or cells were catapulted into
the cap of a test tube (laser pressure catapulting) filled with
mineral oil. The same number of seminiferous tubules (n = 20)
or the same number of seminoma cell clusters of approxi-
mately the same size but from different locations (n = 20)
were collected per tube. Isolated cell profiles were then
dissolved in 350 ml lysis buffer containing b-mercaptoethanol
and 5 ml carrier RNA (RNeasy Micro Kit, Qiagen). RNA from
microdissected human testicular tissue was extracted using
the RNeasy Micro Kit (Qiagen) according to the manu-
facturer’s protocol including the use of carrier RNA and
DNase-I digestion. Equal amounts of RNA were used for
first-strand cDNA synthesis using Sensiscript II reverse tran-
scriptase, as recommended by the manufacturer (Qiagen).
PCR analysis from microdissected seminiferous tubules or
seminoma cells was carried out with the following primer
pairs (accession no, NM_000165): 5V-CCA TCT CTA ACT
CCC ATG CAC AGC-3V as forward primer and 5V-TGG CAC
GAC TGC TGG CTC TGC TT-3V as reverse primer, resulting
in a 137-bp amplicon. PCR conditions were as follows: 1 
95jC for 3 minutes, 15  (95jC for 1 minute, 66jC for 1 min-
ute, 72jC for 2 minutes), 45  (95jC for 1 minute, 62jC for
1 minute, 72jC for 2 minutes), 72jC for 10 minutes. Ten
microliters of cDNA was added to 5 ml 10 PCR buffer (in-
cluding 15mMMgCl2;Qiagen), 10 ml 5Qsolution, 1 ml dNTPs
(Promega, Mannheim, Germany), 0.5 ml Taq polymerase
(5 U/ml; Qiagen), 1 ml of each primer (10 mM), and DEPC-
H2O to a final volume of 50 ml. For internal (methodological)
control due to low amounts of mRNA and for evaluation of
RNA quality, we performed RT-PCR for the housekeeping
gene b-actin (ACTB) from the same RNA samples that were
used for Cx43 amplification. The primer sequences for ACTB
(accession no. BC013835) were 5V-TTC CTT CCT GGG CAT
GGA GT-3V (forward) and 5V-TAC AGG TCT TTG CGG ATG
TC-3V (reverse) resulting in a 90-bp amplicon. PCR conditions
were 1  95jC for 2 minutes, 50  (94jC for 1 minute, 55jC
for 1 minute, 72jC for 1 minute), and 1 72jC for 10minutes.
PCRproductswere separated on a 2%agarose gel, visualized
by SYBR Green (Sigma-Aldrich, Munich, Germany), and
sequenced by Qiagen. Microdissection using serial sections
followed by RT-PCR was repeated at least three times
per patient.
Production of Digoxigenin-Labeled cRNA Probes for ISH
Digoxigenin (DIG)-labeled cRNA probes were generated
as described previously [41]. Briefly, the 137-bp PCR product
of the human Cx43 gene was subcloned in pGEM-T (Pro-
mega). Plasmids were transformed in the XL1-Blue E. coli
strain (Stratagene, Heidelberg, Germany) and extracted by
column purification according to the manufacturers instruc-
tion (Qiagen). After sequencing, vectors containing the Cx43
insert were digested with NcoI and NotI (New England
Biolabs, Frankfurt, Germany) for the production of sense
cRNA (NcoI) and antisense cRNA (NotI), respectively. Sub-
sequently, in vitro transcription was performed using 10
RNA-DIG Labeling Mix (Boehringer Mannheim, Mannheim,
Germany) and RNA polymerases T7 and SP6 (Promega).
In Situ Hybridization
In situ hybridization was performed on biopsies of
10 patients with normal spermatogenesis, on biopsies of
10 patients with CIS, and on 20 biopsies of patients with
seminoma (10  pT1, 6  pT2, 4  pT3) with minor changes
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as described previously [41,42]. Briefly, deparaffinized tissue
sections were incubated in active DEPC water for 2 
12 minutes at 40jC, postfixed in 4% paraformaldehyde for
10 minutes, exposed to 20% acetic acid, and prehybridized
in 20% glycerol for 30 minutes. Sections were then incu-
bated with the DIG-labeled sense or antisense cRNA probes.
Both cRNAs were used at a dilution of 1:25 in hybridization
buffer containing 50% deionized formamide, 10% dextran
sulfate, 2 standard saline citrate (SSC), 1 Denhardt’s
solution, 10 mg/ml salmon sperm DNA (Sigma, Deisenhofen,
Germany), and 10 mg/ml yeast t-RNA (Sigma). Hybridization
was performed overnight at 40jC in a humidified chamber
containing 50% formamide in 2 SSC after posthybridization
washes. Subsequently, sections were incubated with the
anti-DIG Fab antibody conjugated to alkaline phosphatase
(Boehringer) overnight at 4jC. Staining was visualized by
developing sections with nitroblue-tetrazolium/5-bromo-4-
chloro-3-indolyl-phosphate (KPL, Gaithersburg, MD) in a
humidified chamber protected from light. Finally, sections
were rehydrated for 5 minutes in deionized water and then
dehydrated through successive baths of ethanol and xylol,
and mounted in Eukitt resin (Merck, Darmstadt, Germany).
For each test, negative controls were performed using DIG-
labeled cRNA sense probes. Mouse testes were used as
positive control. ISH was repeated at least twice.
Protein Extraction and Western Blot Analysis
For Western blot analysis, testicular biopsies from eight
men were snap frozen in liquid nitrogen and stored at80jC
until further processing. Histologic evaluation of cryosections
of these biopsies before Western blot experiments revealed
normal spermatogenesis in four cases and seminoma in four
cases (2  pT2, 2  pT3). Protein extraction was carried out
using TRIzol reagent as recommended by the manufacturer
(Life Technologies). Cx43 represents a phosphoprotein and
was therefore incubated (10 U/ml, 60 minutes, 37jC) with calf
intestinal alkaline phosphatase (CIP, New England Biolabs)
to elucidate whether variations in electrophoretic mobility
may reflect different phosphorylation states of this protein.
Briefly, same amounts of protein per lane were separated by
sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE) in 10% resolving gels under reducing condi-
tions using the Mini-PROTEAN system (BioRad, Munich,
Germany). Proteins were then blotted onto a Westran poly-
vinylidene fluoride transfer membrane (Schleicher & Schuell,
Dassel, Germany) and blocked with 5% nonfat dry milk
dissolved in 0.1 M phosphate-buffered saline (PBS; pH 7.4)
containing 0.1% Tween for 1 hour under gentle agitation
before treatment with the polyclonal anti-Cx43 antibody
overnight (1:1000; Zytomed, Berlin, Germany). A biotiny-
lated goat anti–rabbit antibody (1:1000; DAKO, Hamburg,
Germany) was used as secondary antibody. The primary and
secondary antibodies were dissolved 1:1000 in PBS buffer.
Finally, the membrane was treated with Vectastain Elite ABC
Kit (Vector, Burlingame, CA) and developed with True Blue
Peroxidase Substrate (KPL). Control Western blots were
carried out by omitting the primary antibody. Western blot
experiments were repeated three times.
Immunohistochemistry (Single and Double Immunostaining)
Single immunohistochemical staining for Cx43 was per-
formed on consecutive sections of the same patients used
for ISH, as described previously [10]. Briefly, sections were
microwave treated for 30minutes at 1000W in sodium citrate
buffer (pH 6.0), blocked with 3% BSA for 30 minutes and
incubated with the polyclonal anti-Cx43 primary antibody
(1:500; Zytomed) overnight at 4jC. Sections were then
exposed to the secondary antibody (1:50, mouse anti–rabbit
IgG, DAKO) followed by the third antibody (1:50, rabbit anti–
mouse IgG, DAKO) and, finally, mouse alkaline phosphatase
anti –alkaline phosphatase (APAAP) antibody complex
(1:100, DAKO) for 30 minutes each. The immunoreaction
was visualized using HistoMark Red (KPL) resulting in a red
color on positive cells.
Double immunostaining for Cx43 and the inhibin-a sub-
unit for the simultaneous detection of Leydig cells in semi-
noma patients was performed as follows: Cx43 and inhibin-a
subunit epitopes were exposed by microwaving three times
for 5 minutes at 1000 W in sodium citrate buffer (pH 6.0) and
then were allowed to stand for an additional 20 minutes. After
blocking with 3% BSA for 30 minutes, rabbit polyclonal anti-
Cx43 primary antibody (Zytomed) was used after diluting
1:500, and tissue sections were incubated overnight at 4jC,
followed by the secondary antibody (1:50; mouse anti–rabbit
IgG; DAKO), by the third antibody (1:50; rabbit anti–mouse
IgG; DAKO), and, finally, by the mouse APAAP antibody
complex (1:100, DAKO) for 30 minutes each. The immuno-
reaction was visualized using NBT/BCIP (KPL) to produce
a blue/pink color on positive cells. Then, the sections were
incubated with 3% H2O2, with 3% BSA for 30 minutes each,
and with the monoclonal primary anti– inhibin-a antibody
(1:50, Serotec, Oxford, UK) overnight at 4jC. On the next
day, sections were incubated with the biotinylated sec-
ondary antibody (1:50; goat anti–mouse IgG, DAKO) and
by incubation using the ABC Kit (Vector) for 30 minutes each.
Immunoreactivity was visualized using diaminobenzidine
(Biologo, Kronshagen, Germany) to produce a brown color
on positive cells. Sections were finally slightly counterstained
with instant hematoxylin (Shandon, Pittsburgh, PA). For each
immunoreaction, control incubations were performed by sub-
stituting buffer for the primary antibody. Experiments were
repeated three times.
Results
cDNA-Microarray Analyses
Microarray analysis identified several up- and down-
regulated genes including Cx43 in three normal testicular
specimens and 40 seminoma of different stages (pT1, n = 22;
pT2, n = 14; pT3, n = 4). The gene expression profiles of
4 samples of tumor stage pT1 were compared with those
of 3 normal tissue samples resulting in 12 single compari-
sons representative for the 43 samples investigated. The
expression of 1490 probe sets was determined as differen-
tially expressed in at least 80% of the comparisons with a
P value <.001 and >.999 for increased and decreased
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changes, respectively. Thereof, the expression of 635 probe
sets was increased and of 855 decreased. For Cx43, two
probe sets were present on the gene array: 2018_at and
32531_at. The first showed very weak signal intensities and
was given as absent, whereas the probes of 32531_at were
positive in 84% of the samples. All 3 normal testicular spec-
imen expressed Cx43 and 32 of 40 seminoma were posi-
tive for this gene. The expression of Cx43 was significantly
9.1-fold downregulated in seminoma tissues (Figure 1A).Cx31
and Cx47 were absent in all samples investigated. Cx32
was expressed only in samples with unimpaired spermato-
genesis and Cx50 was unregulated in 81% of 43 samples.
Cx31.1 was expressed in 87% of 43 samples and 2.1-fold
significantly increased in seminoma compared with normal
testicular specimen. Cx37 was expressed in 27 of 40 semi-
noma tissues with a significant 1.9-fold increase compared
with normal testicular tissues. The down- and upregulated Cx
genes in seminoma versus normal testicular tissue obtained
by microarray analysis are summarized in Table 1.
To confirm the reduced expression of Cx43, semiquanti-
tative RT-PCR using UBB as housekeeping gene were
carried out by investigating 5 samples from normal testicular
specimen and 15 seminoma (Figure 1, B andC). The 2.8-fold
downregulation of Cx43 expression in seminoma was signifi-
cant (Figure 1D). However, the upregulation of Cx31.1 could
not be confirmed by RT-PCR (data not shown).
RT-PCR following Laser Microdissection of Isolated
Seminiferous Tubules and Seminoma Cells
To evaluate Cx43 mRNA expression, microdissection of
whole seminiferous tubules and seminoma cells was per-
formed. Same numbers of seminiferous tubules with normal
spermatogenesis, with CIS cells and residual spermato-
genesis, and tubules showing only CIS and Sertoli cells
(CIS-only tubules), and seminoma cells from different stages
were excised from testicular tissue. Subsequent RT-PCR
analysis of these tubules and/or cell profiles revealed tran-
scripts of Cx43 in tubules showing normal spermatogenesis
and in tubules containing both CIS cells and residual sper-
matogenesis. Tubules resembling only CIS and Sertoli cells
were found either positive (in very few samples) or mostly
negative. Seminoma cells isolated from various sections
exhibiting different seminomatous stages (pT1–pT3)
showed no signal for Cx43 mRNA at all (Figure 2).
Figure 1. (A) cDNA microarray analysis revealed a 9.1-fold downregulation of Cx43-expression in seminoma (tumor stages pT1–pT3). (B) Representative
semiquantitative RT-PCR with UBB as housekeeping gene revealed a strong band for Cx43 at 827 bp in a man with normal spermatogenesis (lane 2) and a 2.8-fold
decrease of Cx43 expression in patients with seminoma stages pT1 (lanes 3 and 4), pT2 (lanes 5 and 6), and pT3 (lanes 7 and 8). Lane 1: 100-bp DNA ladder. (C)
Relative Cx43 mRNA expression compared with UBB and related to tumor stages pT1 to pT3. Here, the representative results from three independent PCR
reactions of 5 normal testis and 15 seminoma specimens (pT1: n = 8, pT2: n = 4, pT3: n = 3) were analyzed. (D) Relative Cx43 mRNA expression in normal testis
and seminoma compared with UBB. NT, normal testis; pT1-3: tumor stages 1 to 3. *P = .016.
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In Situ Hybridization
In seminiferous tubules showing normal spermatogenesis,
Cx43 mRNA was detected around the nuclei of Sertoli
cells (transparent arrows), spermatogonia (transparent arrow-
head) and spermatocytes (black arrow, Figure 3A). No sig-
nal was detectable in the cytoplasm of round spermatids
(Figure 3A, white arrow). Seminiferous tubules from mouse
testis with normal spermatogenesis used as positive con-
trol revealed similar intratubular location for Cx43 mRNA
(Figure 3A, inset).
The expression pattern of Cx43mRNA in CIS-only tubules
(containing both Sertoli cells and CIS cells) was heteroge-
neous. In very few tubules, a hybridization signal was mainly
present in the cytoplasm of Sertoli cells (Sertoli cell nuclei:
transparent arrows; CIS cells are marked with a uniform
line; Figure 3B), whereas in most CIS-only tubules the signal
in Sertoli cells or tumor cells was either markedly reduced
(Figure 3C) or absent (Figure 3D). Note a strong signal in the
cytoplasm of peritubular cells (Figure 3C, white arrowheads)
and endothelial cells of small blood vessels (Figure 3D,
curved black arrow).
In patients revealing pure seminoma, only small cell
clusters (Figure 3E), single cells (Figure 3F, curved trans-
parent arrows), and/or endothelial cells (Figure 3F, inset b)
were found to express Cx43 mRNA, whereas seminoma
cells showed no hybridization signal for Cx43. Control incu-
bations with Cx43 cRNA sense probes were in all cases
negative (Figure 3B, inset, andF, inset a; scale bars = 50 mm).
Immunohistochemistry
In seminiferous tubules showing normal spermato-
genesis, a steady Cx43 staining was detected at the level
of the blood-testis barrier (BTB) between Sertoli cells, be-
tween Sertoli cells and spermatogonia, and between Sertoli
cells and primary spermatocytes (Figure 4A). In addition, a
strong signal was visible between interstitial Leydig cells
(Figure 4A, black arrow).
The expression pattern of Cx43 protein in CIS-only tu-
bules was found to be heterogeneous, corresponding to the
location of Cx43 mRNA. In very few tubules, a disorganized
immunoreactive signal was present at the level of the BTB
(CIS cells: tranparent arrows, Figure 4B). However, in the
majority of these tubules no immunostaining for Cx43 was
detectable (Figure 4C), whereas immunoreactive signals
between adjacent interstitial Leydig cells persisted (Figure 4,
B and C, black arrows).
In seminomatous tissue, only between cells belonging to
single cell clusters within connective tissue (Figure 4D, black
arrow), and between endothelial cells of small blood vessels
(Figure 4E, arrowheads) immunostaining for Cx43 could be
detected independent of staging. Double immunostaining for
Cx43 (blue/pink) and inhibin-a (brown) clearly colocalized
both proteins in the same cell type and identified these cells as
Leydig cells (Figure 4D). Seminoma cells showed no immuno-
reaction for inhibin-a (Figure 4D) or for Cx43 (Figure 4, D
and E; scale bars = 50 mm).
Western Blot Analysis
Normal testicular tissue revealed three immunoreactive
bands between 41 and 45 kDa. Incubation with CIP changed
the electrophoretic profiles of Cx43. Observed bands at
45 kDa (Cx43-P2) and 43 kDa (Cx43-P1) were lost after
CIP treatment resulting in one strong band at 41 kDa (Cx43-
P0). These results indicate that these two bands represent
double- and single-phosphorylated Cx43 isoforms.
In seminoma, only a weak immunoreactive band at 45 kDa
(Cx43-P2) could be demonstrated. In addition, this weak
band was lost after CIP treatment resulting in the Cx43-P0
isoform (Figure 4F, arrow).
Table 1. Expression Data (mRNA) for Cx-Encoding Genes Present on the Microarray in 43 Tissue Samples regarding Different Tumor Stages.
Gene Probe Set ID NCBI ID P-call (%) NT pT1 pT2 pT3
Mean SD Mean SD Mean SD Mean SD
Downregulated connexins
GJA1 Cx43 32531_at X52947 81 3804 1028 476 357 405 394 224 210
GJA8 Cx50 31778_at U34802 5 591 200 87 70 101 92 95 39
GJB1 Cx32 39598_at X04325 7 678 95 338 110 272 122 414 244
GJA7 Cx45 33041_at U03493 65 429 67 406 262 352 96 547 478
Upregulated connexins
GJB5 Cx31.1 38903_at AF099731 91 157 37 301 116 335 96 379 160
GJA4 Cx37 40687_at M96789 63 189 49 354 102 377 90 305 52
Figure 2. Representative RT-PCR from microdissected tubules and semi-
noma cells using primer pairs for Cx43 (A) and -actin (B). Seminiferous
tubules with normal spermatogenesis (lane 2) and seminiferous tubules with
both residual spermatogenesis and CIS (lane 3) revealed a 137-bp PCR
product for Cx43. Tubules resembling only CIS and Sertoli cells (CIS-only
tubules) were found positive or in most cases negative (lanes 4 and 5).
Seminoma cells isolated from different seminomatous stages (pT1–pT3)
showed no signal for Cx43 mRNA (lane 6). Lane 1: 100-bp DNA ladder.
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Figure 3. (A) In normal spermatogenesis, ISH revealed a strong signal for Cx43 mRNA around the nuclei of Sertoli cells (transparent arrows), spermatogonia
(transparent arrowhead), and primary spermatocytes (black arrow). Note an immunonegative spermatogonia (black arrowhead) and immunonegative round
spermatids (white arrow). Seminiferous tubules from mouse testis with normal spermatogenesis used as positive control showed an identical expression pattern
(inset). CIS-only tubules displayed a heterogeneous expression pattern of Cx43 mRNA. In very few tubules, a hybridization signal was mainly present in the
cytoplasm of Sertoli cells (CIS cells are marked with a uniform line; Sertoli cell nuclei: transparent arrows, B). However, in most tubules the signal in Sertoli cells
was either markedly reduced or completely absent (C and D). A strong signal was detectable in the cytoplasm of peritubular cells (white arrowheads, C) and in
endothelial cells of small blood vessels (curved black arrow, D). In seminoma, only single cell clusters (E), single cells (curved transparent arrows, F), and/or
endothelial cells (F, inset b) were found to express Cx43 mRNA, whereas seminoma cells showed no hybridization signal for Cx43. Control incubations with Cx43
cRNA sense probes were in all cases completely negative (B, inset, and F, inset a). Scale bars = 50 m.
Connexin 43 Expression in Seminoma Development Brehm et al. 505
Neoplasia . Vol. 8, No. 6, 2006
Figure 4. In seminiferous tubules showing normal spermatogenesis, a strong immunoreactivity at the level of the blood-testis barrier, apical to spermatogonia,
basal to primary spermatocytes, along the Sertoli cell junctional complexes and between interstitial Leydig cells (black arrow, A) was observed. The expression
pattern of Cx43 protein in CIS-only tubules was found to be heterogeneous. In very few tubules, a disorganized immunoreactive signal was present at the level of
the blood-testis barrier (CIS cells: transparent arrows, B). Most of these tubules were found completely immunonegative for Cx43 protein (C). Leydig cells displayed
a strong and persistent Cx43 immunoreactivity (black arrows, B and C). In seminoma, only between cells of single cell clusters within connective tissue (black
arrow, D) and between endothelial cells of small blood vessels (arrowheads, E) an immunostaining for Cx43 could be detected independent of staging. Double
immunostaining for Cx43 and inhibin-a clearly colocalized both proteins to the same cell type and identified these cells as Leydig cells (arrow, D). Cx43 protein
(blue/pink) was imunolocalized to the plasma membranes of Leydig cells, whereas inhibin-a immunostaining (brown) was detectable in the cytoplasm of the same
cell(s) (D). The tumor cells showed no immunoreaction for Cx43 at all (D and E). Scale bars = 50 m. Representative Western blot analysis (F) from normal
testicular tissue revealed three immunoreactive bands between 41 and 45 kDa (lane 2). Incubation with CIP changed the electrophoretic profiles of Cx43.
Observed bands at 45 (Cx43-P2) and 43 kDa (Cx43-P1) were lost after CIP treatment, resulting in one strong band at 41 kDa (Cx43-P0, lane 3) indicating that
these two former bands represent double- and single phosphorylated Cx43 isoforms. In seminoma, only a weak immunoreactive band at 45 kDa (Cx43-P2) could
be demonstrated (lane 4). In addition, this band was lost after CIP treatment, resulting in the Cx43-P0 isoform (lane 5). In negative controls, no immunoreactive
bands have been observed (lane 6). Lane 1: protein marker.
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Discussion
During normal spermatogenesis, there is a close correla-
tion between Cx43 protein synthesis and Cx43 mRNA ex-
pression, as regulation of Cx43 gene expression is tightly
controlled at the transcriptional level as can be seen by its
stage-dependent expression pattern [43]. Cx43 mRNA was
detectable mainly in the cytoplasm of Sertoli cells, in primary
spermatocytes and spermatogonia. This corresponds to the
location of Cx43 protein between Sertoli cells and between
Sertoli cells and germ cells indicating that these normal germ
cell populations may be capable of synthesizing Cx43 protein
and assembling gap junctions with Sertoli cells. These data
are in accordance with previous studies showing a similar
Cx43 mRNA expression pattern in mouse and human testis
[31,43] and were confirmed by RT-PCR and RT-PCR from
microdissected seminiferous tubules applied in this study.
For the first time, the Cx43 transcript expression pattern
was demonstrated at different stages of human testicular
germ cell neoplasia. The expression of Cx43 mRNA in CIS-
only tubules containing both CIS and Sertoli cells was found
to be variable. The hybridization signal was, in most tu-
bules, either markedly reduced or totally absent. In very few
tubules, however, a signal was mainly present in the cyto-
plasm of Sertoli cells corresponding with our present and
previous immunohistochemical data [10]. This discrepancy of
signal intensity in Sertoli cells between CIS-only tubules may
be an indication of 1) the known existing partial phenotypic
difference of CIS [3], 2) Sertoli cells exhibiting an altered state
of maturation compared to Sertoli cells in other CIS-only tu-
bules, or 3) a more progressive stage of tumor development
toward seminoma. Specific bands for Cx43 using RT-PCR
with testis homogenates from patients showing CIS or CIS-
only (data not shown) and seminoma revealed that Cx43
mRNA was still expressed in neoplastic tissue, due to per-
manent expression of Cx43 in Leydig cells, endothelial cells
and/or peritubular cells. In patients showing seminoma, en-
dothelial cells of small blood vessels and isolated clusters of
Leydig cells were found to be positive for both Cx43 mRNA
and protein. Cx43 and inhibin-a double immunostaining
clearly identified these cell clusters as residual Leydig cell
clusters, in addition to endothelial cells, as the main source of
nonneoplastic cells in seminoma expressing Cx43. Inhibin-a
was chosen as this subunit is known to be expressed in
human Leydig cells [44]. Furthermore, immunohistochemical
stainings revealed no immunoreactive signals for Cx43 be-
tween seminoma cells, suggesting that these cells are un-
able to synthesize Cx43 protein and unable to communicate
through Cx43 gap junction channels, and Western blot anal-
yses performed with seminomatous tissue showed only a
weak immunoreactive band for Cx43 at 45 kDa. This weak
band was identified by CIP treatment as the Cx43-P2 iso-
form. Phosphorylation of Cx43 is known to play a role in its
life cycle, as observations showed that this Cx becomes
phosphorylated before its arrival at the plasma membrane
and is associated with the accretion of connexons into gap
junction plaques [45]. Although Cx43 in nonjunctional plasma
membrane regions is not necessarily phosphorylated, Cx43
located in gap junctions has been reported to be primarily
phosphorylated to the P2 form [45]. The role of Cx43-P2 in
seminoma remains to be elucidated, but this Cx43 iso-
form probably originates from membranous Cx43 in residual
Leydig cells, as can be seen in our present immunohisto-
chemical stainings. However, the observed loss of Cx43-P0
and Cx43-P1 in Leydig cells in seminoma may indicate 1) an
altered or disrupted renewal of these two Cx43 isoforms in
seminoma, 2) a Leydig cell–specific property because it has
been shown that different tissues (cells) exhibit their own char-
acteristic fingerprint of Cx43 phosphorylation [46], or 3) an ab-
errant (compensational) hyperphosphorylated state of Cx43
in these cells, as it is known that neoplastic progression also
influences the function of the remaining Leydig cells [47].
Interestingly, in CIS tubules a more disorganized staining
pattern of Cx43 protein was visible that changed to a com-
plete loss of Cx43 protein in most CIS-only tubules. The phe-
nomenon of an aberrant localization of Cx proteins is well
known [32,36,48,49] and may in these few CIS tubules be
due to a disturbed intracellular trafficking of Cx43 protein or to
the loss of ‘‘normal’’ Sertoli cells as regulators for organized
synthesis and assembly of Cx43 to the plasma membrane.
Microdissection of seminiferous epithelium followed by
RT-PCR analysis showed, in accordance with foregoing
results, that tubules resembling only CIS and Sertoli cells were
found in most cases negative, and that seminoma cells iso-
lated from various sections exhibiting different seminomatous
stages (pT1–pT3) showed no signal for Cx43 mRNA, indi-
cating that loss of Cx43 protein is, inmost cases, accompanied
by a loss of Cx43 mRNA. Similar results were found in semi-
niferous tubules with SCO syndrome; a transcriptional regula-
tion was evident, as there was no synthesis of Cx43 protein
and expression of Cx43 mRNA [31]. Data from our cDNA
microarray analysis showed a 9.1-fold decrease of Cx43
mRNA expression in patients with different stages of semi-
noma compared with patients revealing normal spermatogen-
esis, as confirmed by semiquantitative RT-PCR exhibiting a
2.8-fold decrease of Cx43mRNA. The varying Cx43 transcript
reduction using the two methods is probably caused by the
different methodological approaches, i.e., primers/probes and
the normalization to the housekeeping gene. However, both
data indicate that the tumor suppressor gene Cx43 is signifi-
cantly downregulated with progression to seminoma and that
this downregulation seems to represent a process starting in
CIS tubules. Development of seminoma is known to go along
with an increase in the number of blood vessels,microvascular
density, vascular endothelial growth factor, and thymidine
phosphorylase expression [50,51]. Thus, upregulation of
Cx37 expression in the present study might be explained by
enhanced angiogenesis and formation of new blood vessels
associated with tumor progression.
The etiological role of disorders in gap junctional intercel-
lular communication (GJIC) in carcinogenesis was already
formulated by Loewenstein and Kanno [52], indicating that
tumor cells usually have a low capacity to communicate with
each other. The lack of GJIC in cancer cells was extended
to cancer cell-normal cell communication, and it has been
suggested that this selective communicational isolation of
tumor cells from surrounding normal cells helps to escape
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from signals keeping proliferation in normal tissues under
negative control [53].
Consequently, one possible cause for the still unknown
invasive potential of CIS cells could be their growing inde-
pendence of adjacent Sertoli cells based on their loss of
GJIC through gap junctions that contain Cx43. This is in line
with studies in other organs showing that impaired expres-
sion of Cx43 has been implicated to correlate with neo-
plastic transformation and increased invasiveness [54,55].
Recently it has been shown that regulation of cell prolif-
eration is mediated not by the channel but by an interaction
of the C terminus of Cx43 with an intracellular signaling
cascade [56]. Furthermore, the growth regulator protein
CCN3 (NOV, nephroblastoma overexpressed) seems to me-
diate the growth suppression by binding to the C terminus of
Cx43 in glioma as well as choriocarcinoma cell lines [57,58].
Thus, further investigation is needed to discriminate between
intercellular and intracellular signaling for growth regulation
properties of the Cx.
Consistent with our present and previous study [10],
Wilgenbus et al. [59] failed to identify Cx43 in human tes-
ticular tumors by immunofluorescence. In contrast to our re-
sults, Roger et al. [32] found an aberrant intracytoplasmic
Cx43 immunostaining in seminoma cells of four patients with
seminoma and in the seminoma cell line JKT-1. These re-
sults may be due to the low number of patients investigated
and by the fact that the authors did not consider the expres-
sion of Cx43 in Leydig cells or endothelial cells in semi-
nomatous tissue.
Finally, it is known that normal germ cells exert reciprocal
effects on Sertoli cells and that normal spermatogenic pro-
gression is required for maintenance of Sertoli cells in their
fully differentiated state [60,61]. Interestingly, in human tes-
ticular cancer it has been proposed that cancer progression
may be correlated with an impaired function and altered
differentiation of somatic Sertoli cells [7–11]. Thus, it may
be speculated that reduction of Cx43 in Sertoli cells leads to
an altered state of Sertoli cell maturation and in turn to en-
hanced germ cell proliferation, as Sertoli cells are no longer
able to transmit signals to adjacent CIS cells keeping their
proliferation under negative control.
In conclusion, our data show that progression from CIS
to seminoma is associated with an intratubular reduction or
even loss of Cx43 gene expression and Cx43 protein syn-
thesis mainly in Sertoli cells, indicating that regulation of their
Cx43 expression takes place at transcriptional level. These
changes may further be implicated in the proliferation of CIS
cells in the progression phase of human seminoma de-
velopment. Finally, loss of growth-suppressing signals from
Sertoli cells through Cx43 gap junction channels to adjacent
CIS cells may lead to uncontrolled growth of CIS cells and
their increased invasive potential, which, in turn, results in an
altered state of Sertoli cell maturation.
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